0

Coronary Risk Factors Collection
 1-20 of 265 Articles
ACP Journal Club |  16 August 2016
In adults ≥ 75 years of age with hypertension, intensive vs standard BP-lowering treatment reduced CV events
Paul Shekelle, MD
Ann Intern Med. 2016;165(4):JC14. doi:10.7326/ACPJC-2016-165-4-014
ACP Journal Club |  16 August 2016
Review: In type 2 diabetes, adding dipeptidyl peptidase-4 inhibitors to sulphonylureas increases hypoglycemia
Michael Tanner, MD
Ann Intern Med. 2016;165(4):JC20. doi:10.7326/ACPJC-2016-165-4-020
ACP Journal Club |  19 July 2016
In insulin-treated type 1 diabetes, canagliflozin increased diabetic ketoacidosis
Jad G. Sfeir, MD; Victor M. Montori, MD, MSc
Ann Intern Med. 2016;165(2):JC2. doi:10.7326/ACPJC-2016-165-2-002
ACP Journal Club |  19 July 2016
In adults, quitting smoking abruptly improved abstinence more than quitting gradually
Hannah Wilson, BA; Scott Sherman MD, MPH
Ann Intern Med. 2016;165(2):JC3. doi:10.7326/ACPJC-2016-165-2-003
ACP Journal Club |  19 July 2016
Rosuvastatin reduced major cardiovascular events in patients at intermediate cardiovascular risk
Charles B. Eaton MD, MS
Ann Intern Med. 2016;165(2):JC6. doi:10.7326/ACPJC-2016-165-2-006
ACP Journal Club |  19 July 2016
Combination candesartan–HCTZ did not reduce major CV events in patients at intermediate CV risk
Charles B. Eaton MD, MS
Ann Intern Med. 2016;165(2):JC7. doi:10.7326/ACPJC-2016-165-2-007
ACP Journal Club |  19 July 2016
Adding candesartan-HCTZ to rosuvastatin increased adverse events but not benefits in patients at intermediate CV risk
Charles B. Eaton MD, MS
Ann Intern Med. 2016;165(2):JC8. doi:10.7326/ACPJC-2016-165-2-008
ACP Journal Club |  19 July 2016
Incretin-based drugs were not linked to HF hospitalization compared with other oral antidiabetic drug combinations
Donald A. Smith, MD, MPH
Ann Intern Med. 2016;165(2):JC11. doi:10.7326/ACPJC-2016-165-2-011
ACP Journal Club |  21 June 2016
Review: In diabetes, benefits of lowering BP depend on baseline BP being 140 mm Hg or more
Laura Larrea Mantilla, MD; Victor M. Montori, MD, MSc
Ann Intern Med. 2016;164(12):JC62. doi:10.7326/ACPJC-2016-164-12-062
ACP Journal Club |  21 June 2016
Review: Providing genetic-based risk estimates for disease does not affect risk-reducing behaviors in adults
Charles B. Eaton, MD, MS
Ann Intern Med. 2016;164(12):JC65. doi:10.7326/ACPJC-2016-164-12-065
ACP Journal Club |  21 June 2016
Modified Framingham Risk Score predicted 10-y CAD better than the original score in patients with lupus
David S. Pisetsky, MD, PhD
Ann Intern Med. 2016;164(12):JC71. doi:10.7326/ACPJC-2016-164-12-071
ACP Journal Club |  17 May 2016
Varenicline, combination NRT, and nicotine patch did not differ for smoking cessation at 6 mo
Brian A. Primack, MD, PhD
Ann Intern Med. 2016;164(10):JC54. doi:10.7326/ACPJC-2016-164-10-054
ACP Journal Club |  19 April 2016
Review: In older persons at vascular risk, statins do not prevent dementia or cognitive decline at 3.5 to 5 years
Eric B. Larson, MD, MPH
Ann Intern Med. 2016;164(8):JC42. doi:10.7326/ACPJC-2016-164-8-042
ACP Journal Club |  19 April 2016
Varenicline increased smoking cessation at 24 weeks in patients hospitalized with ACS and motivated to quit
Allan V. Prochazka, MD, MSc
Ann Intern Med. 2016;164(8):JC43. doi:10.7326/ACPJC-2016-164-8-043
ACP Journal Club |  15 March 2016
Review: PCSK9 inhibitors reduce mortality but increase neurocognitive events in hypercholesterolemia
Raul D. Santos, MD, PhD
Ann Intern Med. 2016;164(6):JC31. doi:10.7326/ACPJC-2016-164-6-031
ACP Journal Club |  15 March 2016
In adults without CVD, the MESA score, including coronary artery calcium, predicted 10-y risk for CHD events
Donald A. Smith, MD, MPH, FACP
Ann Intern Med. 2016;164(6):JC35. doi:10.7326/ACPJC-2016-164-6-035
ACP Journal Club |  16 February 2016
Review: More- vs less-intensive BP-lowering regimens reduce major CV events
Saurav Chatterjee, MD; Partha Sardar, MD; Anasua Chakraborty, MD; et al.
Ann Intern Med. 2016;164(4):JC14. doi:10.7326/ACPJC-2016-164-4-014
ACP Journal Club |  16 February 2016
In patients with SBP ≥ 130 mm Hg and CV risk, intensive vs standard BP control reduced CV events and mortality
Saurav Chatterjee, MD; Partha Sardar, MD; Anasua Chakraborty, MD; et al.
Ann Intern Med. 2016;164(4):JC15. doi:10.7326/ACPJC-2016-164-4-015
ACP Journal Club |  16 February 2016
In resistant hypertension, add-on spironolactone reduced SBP more than placebo, doxazosin, or bisoprolol over 12 wk
Mark Rosenberg, MD; Elizabeth Stephens, MD
Ann Intern Med. 2016;164(4):JC16. doi:10.7326/ACPJC-2016-164-4-016
ACP Journal Club |  16 February 2016
In abstinent adults with type 2 diabetes, a daily glass of wine (vs mineral water) improved cardiometabolic factors
Meera Jain, MD; Richard Wernick, MD
Ann Intern Med. 2016;164(4):JC17. doi:10.7326/ACPJC-2016-164-4-017
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)